Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  ACB | T.ACB.WS.U

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Post by Duediligence33on Sep 11, 2020 10:07am
108 Views
Post# 31541901

Re : Cron and ACB

Re : Cron and ACBI agree Cron has a paltry revenue compared to ACB but O included them as winners with Canopy and Aphria because they had over 1 billion USD in cash and a huge American giant Altria thst owns 45 % of the company and they will NEVER go bankrupt. When the US legalizes then Altria will pour in more billions and just buy out the company so that is safe although right now they have low revenue as the Canadian market sucks for everybody. Canopy has Constellation beverage with over 2 billion in cash and Aphria is the only regular positive EBITDA MJ company with cash and low debt and great facilities. ACB has for a partner Noooooooobody and has debt with low cash and declining revenue and declining market share. This is a death spiral to CCAA. My advice is even now sell ACB and buy CGC or APH or Cron. The longs are deer in headlights shocked and frozen to action from the huge losses on paper. Dont fear to sell and buy the winners
<< Previous
Bullboard Posts
Next >>